跳至主要内容
临床试验/NCT06128720
NCT06128720招募中不适用

A Randomized, Sham Controlled, Masked Phase II Study to Evaluate the Neuroprotective Effect of Hyperbaric Oxygen Therapy on Optic Neuropathy

Stanford University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Change in Visual Field- Mean Deviation

研究概览

简要总结

The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must meet all of the following criteria to join the study (all eligibility criteria must be met at the screening and baseline visits unless otherwise noted):
  • Participant must be at least
  • Participant must has the ability to comply with the requirements of the study and complete the schedule of events (SOE).
  • Participant's with clinical evidence of optic neuropathy.
  • Participant must understand and sign the informed consent. If the participant's vision is impaired to the point where he/she cannot read the informed consent document, the document will be read to the participant in its entirety.

排除标准

  • Participant is unable to comply with study procedures or follow-up visits.
  • Participant has evidence of corneal opacification or lack of optical clarity.
  • Participant is currently participating in or has within the last 3 months participated in any other clinical trial of a drug by ocular (if in the study eye) or systemic administration.
  • Participant is pregnant or lactating.
  • Participant has, in the opinion of the investigator, any physical or mental condition that would increase the risk of participation in the study or may interfere with the study procedures, evaluations and outcome assessments.
  • Children and comatose patients.
  • Participant abusing drugs or alcohol.
  • Prior treatment with hyperbaric oxygen within the last 6 months.
  • Participant with claustrophobia or that cannot decompress properly.

结局指标

主要结局

Change in Visual Field- Mean Deviation

时间窗: Baseline through 6 months

Humphrey visual field testing with standard MD output

Change in Visual Field- Visual Field Index

时间窗: Baseline through 6 months

Humphrey visual field testing with standard VFI output

次要结局

  • Change in Average Thickness Ganglion Cell Complex on Optical Coherence Tomography(Baseline through 6 months)
  • Change in Average Thickness Retinal Nerve Fiber Layer on Optical Coherence Tomography(Baseline through 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey L Goldberg

Professor of Ophthalmology

Stanford University

研究点 (2)

Loading locations...

相似试验